Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Juan F. Gallegos‐Orozco, Velimir A. Luketic et al.|Gastroenterology|2016Cited by 1k
Increased Adipose Tissue Expression of Hepcidin in Severe Obesity Is Independent From Diabetes and NASHSoumeya Bekri, Y. Le Marchand‐Brustel, Philippe Gual et al.|Gastroenterology|2006Cited by 491
Hepatic Expression Patterns of Inflammatory and Immune Response Genes Associated with Obesity and NASH in Morbidly Obese PatientsAdeline Bertola, Philippe Gual, Stéphanie Bonnafous et al.|PLoS ONE|2010Cited by 234
The Inflammatory C-Reactive Protein Is Increased in Both Liver and Adipose Tissue in Severely Obese Patients Independently from Metabolic Syndrome, Type 2 Diabetes, and NASHRodolphe Anty, Philippe Gual, Soumeya Bekri et al.|The American Journal of Gastroenterology|2006Cited by 185
Liquid Chromatography−Mass Spectrometry-Based Parallel Metabolic Profiling of Human and Mouse Model Serum Reveals Putative Biomarkers Associated with the Progression of Nonalcoholic Fatty Liver DiseaseJonathan Barr, José M. Mato, Mercedes Vázquez–Chantada et al.|Journal of Proteome Research|2010Cited by 165